Daito Pharmaceutical Co., Ltd. (4577) Other
Market cap
¥37.5B
P/E ratio
14.8x
Daito manufactures active pharmaceutical ingredients and prescription drugs for domestic and international pharmaceutical companies. The company offers an integrated production system from raw materials to final formulations.
| 2012/05 | 2013/05 | 2014/05 | 2015/05 | 2016/05 | 2017/05 | 2018/05 | 2019/05 | 2020/05 | 2021/05 | 2022/05 | 2023/05 | 2024/05 | 2025/05 | 2026/05 | |
| Return on Assets | - | - | - | - | 6 | 6 | 6.6 | 7.5 | 7.8 | 7.6 | 7.6 | 5.3 | 4.4 | 2.5 | 10.3 |
| Return on equity (%) | - | - | - | ||||||||||||
| Employees | 560 | 579 | 615 | 664 | 712 | 726 | 734 | 735 | 784 | 846 | 915 | 1,011 | 1,070 | 1,073 | - |
| Total payout ratio | - | - | - | 21.1 | 14.7 | 14.2 | 13.6 | 12.8 | 12.7 | 15.5 | 14.1 | 28.9 | 63.2 | 85 | 35.2 |